Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Abu Dhabi Investment Authority is the direct owner of 1,669,576 of the shares of Common Stock represented herein. (2) The percent calculation is based on 53,984,337 shares of Common Stock outstanding, after giving effect to the completion of the offering as described in Eikon Therapeutics, Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on February 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Platinum Falcon B 2018 RSC Limited ("Platinum Falcon") is the direct owner of 1,147,138 of the shares of Common Stock reported herein. Platinum Falcon is a wholly owned subsidiary of Abu Dhabi Investment Authority. Pursuant to the rules and regulations of the Securities and Exchange Commission, Abu Dhabi Investment Authority may be deemed to be the beneficial owner of the shares of Common Stock directly held by Platinum Falcon. (2) The percent calculation based on 53,984,337 shares of Common Stock outstanding after giving effect to the completion of the offering as described in Eikon Therapeutics, Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on February 5, 2026.


SCHEDULE 13G



 
Abu Dhabi Investment Authority
 
Signature:/s/ Saif Surour Omair Maaded AlMashghouni
Name/Title:Authorized Signatory
Date:02/18/2026
 
Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
Name/Title:Authorized Signatory
Date:02/18/2026
 
Platinum Falcon B 2018 RSC Limited
 
Signature:/s/ Saif Surour Omair Maaded AlMashghouni
Name/Title:Authorized Signatory
Date:02/18/2026
 
Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
Name/Title:Authorized Signatory
Date:02/18/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement